Chemical inhibitors of BB146404 encompass a range of compounds that disrupt various signaling pathways and cellular processes, consequently inhibiting the function of this protein. Staurosporine serves as a broad-spectrum protein kinase inhibitor and can inhibit BB146404 by targeting its kinase activity directly, assuming that BB146404 has kinase activity or interacts with protein kinases. LY294002 and Wortmannin, both PI3K inhibitors, can inhibit BB146404 by disrupting the PI3K/Akt signaling pathway, which is pivotal for cell survival and proliferation, thereby impacting the functional role of BB146404 within this pathway. Similarly, PD98059 and U0126, which are specific MEK inhibitors, can inhibit BB146404 by obstructing the MAPK/ERK pathway, a critical route for cell cycle control and differentiation, possibly linked with BB146404's activity.
Further, SB203580 and SP600125, which inhibit p38 MAPK and JNK respectively, can inhibit BB146404 by impeding the signaling pathways responsible for stress responses and apoptosis that may involve BB146404. Rapamycin, an mTOR inhibitor, can inhibit BB146404 by blocking the mTORC1 complex within the mTOR signaling pathway, which is significant for cell growth and protein synthesis. Bortezomib, by inhibiting the proteasome, can inhibit BB146404 by stabilizing proteins that control apoptosis, cell cycle, and growth, potentially affecting the regulatory role of BB146404. ZM-447439 targets Aurora kinases and can inhibit BB146404 by disrupting chromosome alignment and segregation during cell division, processes that BB146404 may influence. Sotrastaurin, by selectively inhibiting PKC, can inhibit BB146404 by altering PKC-mediated signal transduction, which may be relevant to BB146404's role in cellular differentiation and proliferation. Lastly, AG-490, as a JAK2 inhibitor, can inhibit BB146404 by interfering with the JAK/STAT signaling pathway, which is crucial for regulating cell growth and immune response, indicating the potential involvement of BB146404 in these processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A potent non-selective inhibitor of protein kinases, Staurosporine can inhibit BB146404 by impeding its kinase activity, assuming BB146404 possesses or interacts with kinase domains. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A specific inhibitor of PI3K, LY294002 can inhibit BB146404 by disrupting the PI3K/Akt signaling pathway, which may be crucial for BB146404's function related to cell survival and growth. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Similarly a PI3K inhibitor, Wortmannin can inhibit BB146404 by blocking the PI3K pathway, leading to reduced Akt phosphorylation and activity, potentially impacting BB146404's role in this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An MEK inhibitor, PD98059 can inhibit BB146404 by preventing the activation of the MAPK/ERK pathway, which could be essential for BB146404's function if it is involved in this signaling cascade. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
This p38 MAPK inhibitor can inhibit BB146404 by blocking the p38 MAPK signaling pathway, which is involved in stress responses, and may be important for BB146404's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, SP600125 can inhibit BB146404 by hindering the JNK signaling pathway, which can regulate apoptosis and cellular proliferation, possibly related to the activity of BB146404. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
By inhibiting MEK1/2, U0126 can inhibit BB146404 by disrupting the MEK/ERK pathway, which may be a pathway that BB146404 is part of, affecting its role in cell cycle regulation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, Rapamycin can inhibit BB146404 by blocking the mTOR signaling pathway, potentially impacting protein synthesis and growth signals that BB146404 could be influencing. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
As a proteasome inhibitor, Bortezomib can inhibit BB146404 by preventing the degradation of regulatory proteins that control cell cycle, growth, and apoptosis, processes that BB146404 may regulate. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $150.00 $349.00 | 15 | |
An Aurora kinase inhibitor, ZM-447439 can inhibit BB146404 by preventing phosphorylation events necessary for chromosome alignment and segregation, which could be critical for BB146404's function in cell division. |